Newcardio Stock Today

Performance

Very Weak

 
Weak
 
Strong

Odds Of Distress

Low

 
High
 
Low
NewCardio has only a 6 % chance of going through financial distress over the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 16th of December 2024 and ending today, the 16th of March 2025. Click here to learn more.
Business Domain
Health Care Equipment & Services
Category
Healthcare
Classification
Health Care
NewCardio, Inc., a cardiac diagnostic and services company, focuses on the research, development, and commercialization of proprietary software platform technology solutions for the non-invasive diagnosis and monitoring of cardiovascular disease , as well as the cardiac safety assessment of drugs under development. The company has 33.15 M outstanding shares. More on NewCardio
NewCardio cannot be verified against its exchange. Apparently, NewCardio is not available for investing at the moment. Please verify the symbol is currently traded on OTCCE Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Refresh

NewCardio Stock Highlights

Business ConcentrationHealth Care Technology, Health Care Equipment & Services, Health Care, Health Care, Health Care Technology, Medical Devices, Healthcare (View all Sectors)
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.09860.1
Fairly Down
Slightly volatile
Gross Profit Margin0.280.37
Way Down
Very volatile
Total Current Liabilities4.4 M4.2 M
Sufficiently Up
Slightly volatile
Total Assets3.3 M2.6 M
Significantly Up
Slightly volatile
Total Current Assets3.2 M2.4 M
Significantly Up
Slightly volatile
NewCardio (NWCI) is traded on OTCCE Exchange in USA and employs 10 people. NewCardio is listed under Health Care Technology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 49.72 K. NewCardio conducts business under Health Care Technology sector and is part of Health Care industry. The entity has 33.15 M outstanding shares. NewCardio currently holds about 13.06 K in cash with (4.56 M) of positive cash flow from operations.
Check NewCardio Probability Of Bankruptcy

NewCardio Stock Against Markets

Try Other Suggestions

NW New World ResourceCompanyDelisted
NWE NorthWesternCompany
NWWJX Nationwide Investor DestinationsMutual Fund
NWLG Nuveen Winslow Large CapETF
NWX ARCA NetworkingIndex
When determining whether NewCardio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NewCardio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Newcardio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Newcardio Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NewCardio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For more detail on how to invest in NewCardio Stock please use our How to Invest in NewCardio guide.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NewCardio. If investors know NewCardio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NewCardio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share
0.008
Quarterly Revenue Growth
(0.90)
Return On Assets
(2.24)
The market value of NewCardio is measured differently than its book value, which is the value of NewCardio that is recorded on the company's balance sheet. Investors also form their own opinion of NewCardio's value that differs from its market value or its book value, called intrinsic value, which is NewCardio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NewCardio's market value can be influenced by many factors that don't directly affect NewCardio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NewCardio's value and its price as these two are different measures arrived at by different means. Investors typically determine if NewCardio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NewCardio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.